BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35326597)

  • 21. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
    Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
    Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.
    Garciaz S; Hospital MA; Alary AS; Saillard C; Hicheri Y; Mohty B; Rey J; D'Incan E; Charbonnier A; Villetard F; Maisano V; Lombardi L; Ittel A; Mozziconacci MJ; Gelsi-Boyer V; Vey N
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial metabolism: powering new directions in acute myeloid leukemia.
    Stubbins RJ; Maksakova IA; Sanford DS; Rouhi A; Kuchenbauer F
    Leuk Lymphoma; 2021 Oct; 62(10):2331-2341. PubMed ID: 34060970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATP directed agent, 8-chloro-adenosine, induces AMP activated protein kinase activity, leading to autophagic cell death in breast cancer cells.
    Stellrecht CM; Vangapandu HV; Le XF; Mao W; Shentu S
    J Hematol Oncol; 2014 Mar; 7():23. PubMed ID: 24628795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels.
    Stellrecht CM; Ayres M; Arya R; Gandhi V
    Breast Cancer Res Treat; 2010 Jun; 121(2):355-64. PubMed ID: 19641990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.
    Sheth AI; Althoff MJ; Tolison H; Engel K; Amaya ML; Krug AE; Young TN; Minhajuddin M; Pei S; Patel SB; Winters A; Miller R; Shelton IT; St-Germain J; Ling T; Jones CL; Raught B; Gillen AE; Ransom M; Staggs S; Smith CA; Pollyea DA; Stevens BM; Jordan CT
    Cancer Discov; 2024 May; ():. PubMed ID: 38787341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment.
    Tabe Y; Konopleva M
    Cancer Drug Resist; 2023; 6(1):138-150. PubMed ID: 37065866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclax.
    Kapadia B; Shetty AC; Bollino D; Bhandary B; Lapidus RG; Mahmood K; Mahurkar A; Gartenhaus RB; Eckert RL; Emadi A
    Exp Hematol; 2022 Apr; 108():55-63. PubMed ID: 35104581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular succinylation of 8-chloroadenosine and its effect on fumarate levels.
    Dennison JB; Ayres ML; Kaluarachchi K; Plunkett W; Gandhi V
    J Biol Chem; 2010 Mar; 285(11):8022-30. PubMed ID: 20064937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation.
    Liu F; Kalpage HA; Wang D; Edwards H; Hüttemann M; Ma J; Su Y; Carter J; Li X; Polin L; Kushner J; Dzinic SH; White K; Wang G; Taub JW; Ge Y
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [8-Chloro-adenosine increases the activity of transcription factor CREB by modification of phosphorylation].
    Chang XY; Fang JC; Wang NQ; Liu T; Su H
    Ai Zheng; 2003 Apr; 22(4):350-3. PubMed ID: 12703986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA-directed actions of 8-chloro-adenosine in multiple myeloma cells.
    Stellrecht CM; Rodriguez CO; Ayres M; Gandhi V
    Cancer Res; 2003 Nov; 63(22):7968-74. PubMed ID: 14633728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of p53 and p21 on 8-chloro-adenosine-induced cellular response.
    Teakell S; Chen LS; Stellrecht CM; Gandhi V
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(12):1359-1374. PubMed ID: 35227162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.
    Sheth AI; Engel K; Tolison H; Althoff MJ; Amaya ML; Krug A; Young T; Pei S; Patel SB; Minhajuddin M; Winters A; Miller R; Shelton I; St-Germain J; Ling T; Jones C; Raught B; Gillen A; Ransom M; Staggs S; Smith CA; Pollyea DA; Stevens BM; Jordan CT
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells.
    Sun M; Zhang J; Liu S; Liu Y; Zheng D
    Oncol Rep; 2008 Jan; 19(1):177-85. PubMed ID: 18097593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Short-term efficacy of venetoclax combined with azacitidine in acute myeloid leukemia: a single-institution experience].
    Yu WJ; Jia JS; Wang J; Tang FF; Gong LZ; Liu XH; Zhu XL; Zhao XS; Huang XJ; Jiang H
    Zhonghua Xue Ye Xue Za Zhi; 2022 Feb; 43(2):134-140. PubMed ID: 35381674
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.
    Gandhi V; Chen W; Ayres M; Rhie JK; Madden TL; Newman RA
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):85-94. PubMed ID: 12172971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of CHK1 kinase by Gö6976 converts 8-chloro-adenosine-induced G2/M arrest into S arrest in human myelocytic leukemia K562 cells.
    Jia XZ; Yang SY; Zhou J; Li SY; Ni JH; An GS; Jia HT
    Biochem Pharmacol; 2009 Mar; 77(5):770-80. PubMed ID: 19059218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Mitochondrial Oxidative Phosphorylation Eradicates Acute Myeloid Leukemic Stem Cells.
    Peng M; Huang Y; Zhang L; Zhao X; Hou Y
    Front Oncol; 2022; 12():899502. PubMed ID: 35574326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venetoclax-Resistant MV4-11 Leukemic Cells Activate PI3K/AKT Pathway for Metabolic Reprogramming and Redox Adaptation for Survival.
    Alkhatabi HA; Zohny SF; Shait Mohammed MR; Choudhry H; Rehan M; Ahmad A; Ahmed F; Khan MI
    Antioxidants (Basel); 2022 Feb; 11(3):. PubMed ID: 35326111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.